← All trials
NCT02624843
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2015
- Primary completion
- Nov 1, 2015
- Completion date
- Nov 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 225
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Akorn, Inc.Lead sponsor
- AXIS Clinicals LimitedCollaborator
- South Florida Family Health and Research CentersOverall official - principal investigator
- AXIS Clinicals LimitedOverall official - principal investigator
- Insect Research and Development LTDStudy director
- South Florida Family Health and Research CentersCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.